Paper28782884
Chronic lymphocytic leukemia: 2017 update on diagnosis, risk stratification, and treatment.
Hallek M. Am J Hematol, 2017. Cited by 193 papers, by iCite.
Cite this record
ConductScience Library. Chronic lymphocytic leukemia: 2017 update on diagnosis, risk stratification, and treatment. Papers, record 28782884. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28782884
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Chronic lymphocytic leukemia: 2017 update on diagnosis, risk stratification, and treatment.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Combined Chemotherapy Protocols | Major topic |
| Chromosome Deletion | Major topic |
| Leukemia, Lymphocytic, Chronic, B-Cell | Major topic |
| Smith-Magenis Syndrome | Major topic |
| Tumor Suppressor Protein p53 | Major topic |
| Adenine | |
| Antibodies, Monoclonal | |
| Antibodies, Monoclonal, Humanized | |
| Chromosomes, Human, Pair 17 | |
| Humans | |
| Piperidines | |
| Pyrazoles | |
| Pyrimidines | |
| Risk Assessment | |
| Rituximab |
Source PubMed
Cited by135
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 193 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42458174 | Safety and Management of Targeted Therapies for Relapsed/Refractory Chronic Lymphocytic Leukemia. | Drug Saf | 2026 | https://conductscience.org/library/papers/42458174 | PubMed |
| 42450116 | Complex TP53 Alterations with del(17p) and del(13q) in Chronic Lymphocytic Leukemia: Clinical Implications from a Case-Based Review. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42450116 | PubMed |
| 42001129 | Concurrent hepatic cirrhosis and chronic lymphocytic leukemia: a challenging coexistence: a case report. | J Med Case Rep | 2026 | https://conductscience.org/library/papers/42001129 | PubMed |
| 41673825 | Pretreatment immunoglobulin profiles and survival outcomes in hematologic malignancies and autoimmune cytopenias: a comparative cohort analysis. | BMC Immunol | 2026 | https://conductscience.org/library/papers/41673825 | PubMed |
| 41181769 | Comparison of One-Year Adverse Events Between First- and Second-Generation Bruton's Tyrosine Kinase Inhibitors: A Retrospective Study. | Cureus | 2025 | https://conductscience.org/library/papers/41181769 | PubMed |
| 40996474 | Chronic lymphocytic leukemia: criteria for first-line therapeutic choice-an opinion paper. | Med Oncol | 2025 | https://conductscience.org/library/papers/40996474 | PubMed |
| 40886283 | Circular RNAs and Cancers. | Adv Exp Med Biol | 2025 | https://conductscience.org/library/papers/40886283 | PubMed |
| 40569983 | Global, regional, and national burden of leukemia: Epidemiological trends analysis from 1990 to 2021. | PLoS One | 2025 | https://conductscience.org/library/papers/40569983 | PubMed |
| 39606680 | Overview on Immunopathology of Chronic Lymphocytic Leukemia and Tumor-Associated Antigens with Therapeutic Applications. | Avicenna J Med Biotechnol | 2024 | https://conductscience.org/library/papers/39606680 | PubMed |
| 39417189 | Molecular significance of circRNAs in malignant lymphoproliferative disorders: pathogenesis and novel biomarkers or therapeutic targets. | Am J Cancer Res | 2024 | https://conductscience.org/library/papers/39417189 | PubMed |
| 39202022 | Integrative Analysis of Multi-Omics Data to Identify Deregulated Molecular Pathways and Druggable Targets in Chronic Lymphocytic Leukemia. | J Pers Med | 2024 | https://conductscience.org/library/papers/39202022 | PubMed |
| 38920669 | Lysosome-Disrupting Agents in Combination with Venetoclax Increase Apoptotic Response in Primary Chronic Lymphocytic Leukemia (CLL) Cells Mediated by Lysosomal Cathepsin D Release and Inhibition of Autophagy. | Cells | 2024 | https://conductscience.org/library/papers/38920669 | PubMed |
| 38469292 | An unappreciated cell survival-independent role for BAFF initiating chronic lymphocytic leukemia. | Front Immunol | 2024 | https://conductscience.org/library/papers/38469292 | PubMed |
| 38443660 | Final results on effectiveness and safety of Ibrutinib in patients with chronic lymphocytic leukemia from the non-interventional FIRE study. | Ann Hematol | 2025 | https://conductscience.org/library/papers/38443660 | PubMed |
| 38426852 | The global burden of childhood and adolescent leukaemia and attributable risk factors: An analysis of the Global Burden of Disease Study 2019. | J Glob Health | 2024 | https://conductscience.org/library/papers/38426852 | PubMed |
| 38348963 | Real-world analysis of adverse event rates after initiation of ibrutinib among Medicare beneficiaries with chronic lymphocytic leukemia. | Cancer Med | 2024 | https://conductscience.org/library/papers/38348963 | PubMed |
| 38174814 | Maintenance therapy for chronic lymphocytic leukaemia. | Cochrane Database Syst Rev | 2024 | https://conductscience.org/library/papers/38174814 | PubMed |
| 37900812 | Delayed Diagnosis of T-Cell Prolymphocytic Leukemia: Approach to Chronic Lymphocytosis. | Case Rep Oncol | 2023 | https://conductscience.org/library/papers/37900812 | PubMed |
| 37770269 | Protocol for a multicentre randomised controlled trial examining the effects of temporarily pausing Bruton tyrosine kinase inhibitor therapy to coincide with SARS-CoV-2 vaccination and its impact on immune responses in patients with chronic lymphocytic leukaemia. | BMJ Open | 2023 | https://conductscience.org/library/papers/37770269 | PubMed |
| 37426051 | Determinants of Time-to-Death of Chronic Lymphocytic Leukemia Patients at Felege Hiwot Referral Hospital, Bahir Dar, Ethiopia. | Cancer Inform | 2023 | https://conductscience.org/library/papers/37426051 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD5 | 921 | PubTator's text mining | https://conductscience.org/library/genes/921 | NCBI Gene |
| KRT20 | 54474 | PubTator's text mining | https://conductscience.org/library/genes/54474 | NCBI Gene |
| TP53 | 7157 | PubTator's text mining | https://conductscience.org/library/genes/7157 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/28782884
GET https://conductscience.org/api/papers/v1/28782884/cited_by?page=2